Monday, February 7, 2022

< + > Japan Could Fast Track Shionogi’s New Antiviral Pill To Treat Covid After Promising Trial Data

The drug reduced the amount of virus in patients by as much as 80%, according to data from Shionogi’s small clinical trial.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Health Recovery Solutions Acquires Rimidi | Messagepoint Acquires Sefas

Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare ...